NLS Pharmaceutics Ltd. - Ordinary Shares (NQ:NLSP)

0.7620 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NLS Pharmaceutics Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity

January 23, 2023

Via ACCESSWIRE

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 17, 2023

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...

Via Benzinga

NLS Pharmaceutics Announces Purchase Agreement with BVF Partners L.P. to Raise Aggregate Gross Proceeds of up to $30 Million

December 07, 2022

Via ACCESSWIRE

NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds

January 12, 2023

Via ACCESSWIRE

NLS Pharmaceutics Announces Compliance with Nasdaq Bid Price Requirement

January 12, 2023

Via ACCESSWIRE

NLS Pharmaceutics to Participate in Upcoming Investor Conferences

January 11, 2023

Via ACCESSWIRE

NLS Pharmaceutics Announces Technology Patent Grant Covering Mazindol for Treatment of Attention Deficit Hyperactivity Disorder and Rare Sleep Disorders in Hong Kong

January 10, 2023

Via ACCESSWIRE

NLS Pharmaceutics CEO Issues Letter to Shareholders

December 22, 2022

Via ACCESSWIRE

NLS Pharmaceutics Announces Israeli Patent Grant Covering Mazindol for Treatment of Attention Deficit Hyperactivity Disorder and Other Sleep Disorders Through 2037

December 20, 2022

Via ACCESSWIRE

NLS Pharmaceutics Announces Closing of Initial Tranche of US$10.0 Million Purchase Agreement with BVF Partners L.P.

December 14, 2022

Via ACCESSWIRE

NLS Pharmaceutics Announces Receipt of Nasdaq Minimum Bid Price Notification

December 07, 2022

Via ACCESSWIRE

NLS Pharmaceutics Announces Notice of Allowance for U.S. Patent Covering Mazindol for Opioid Dependence and Substance Use Disorder

December 01, 2022

Via ACCESSWIRE

Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗

November 28, 2022

Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.

Via Benzinga

Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session ↗

November 25, 2022

Gainers Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08.

Via Benzinga

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗

November 25, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.

Via Benzinga

NLS Pharmaceutics Announces Launch of Paid for Named Patient Program with Mazindol ER for Idiopathic Hypersomnia, a Serious Sleep Disorder with No Approved Treatment Options in Europe

November 23, 2022

Via ACCESSWIRE

NLS Pharmaceutics Successfully Appeals Nasdaq Delisting Notice

November 14, 2022

Via ACCESSWIRE

NLS Pharmaceutics Provides Open Label Extension Study Update for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy

November 07, 2022

Via ACCESSWIRE

U.S. FDA Grants Orphan Drug Designation (ODD) for Quilience(R) (Mazindol ER) for the Treatment of Idiopathic Hypersomnia (IH)

November 02, 2022

Via ACCESSWIRE

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session ↗

October 14, 2022

Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.

Via Benzinga

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

October 21, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.

Via Benzinga

Why Leggett & Platt Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket ↗

October 11, 2022

Gainers Vox Royalty Corp. (NASDAQ: VOXR) rose 60.4% to $4.33 in pre-market trading. Vox Royalty’s common shares commenced trading on The Nasdaq Stock Market on Monday.

Via Benzinga

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday ↗

October 17, 2022

Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 11, 2022

Good morning, trader! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Via InvestorPlace

Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday ↗

October 12, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.

Via Benzinga

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

October 05, 2022

Via ACCESSWIRE

Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗

October 11, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939.

Via Benzinga

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.